Literature DB >> 12908935

Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa.

Geoffrey S Gottlieb1, Papa Salif Sow, Stephen E Hawes, Ibra Ndoye, Awa M Coll-Seck, Marcel E Curlin, Cathy W Critchlow, Nancy B Kiviat, James I Mullins.   

Abstract

Dual infection with HIV-1 and HIV-2 can occur in locales where these viruses co-circulate, most commonly in West Africa. Although dual seropositivity is common in this region, the true rate of dual infection remains unclear. In addition, whether unique HIV-1 subtypes are circulating in dually infected individuals is unknown. A cohort of 47 HIV-1 and HIV-2 dually seropositive individuals from Senegal, West Africa was screened for the presence of HIV-1 and HIV-2 gag and env PBMC viral DNA sequences using PCR. Of the 47 dual HIV-1/HIV-2 seropositive individuals tested, 19 (40.4%) had infection with both HIV-1 and HIV-2 confirmed by genetic sequence analysis, whereas only HIV-1 or HIV-2 was confirmed in 17 (36.2%) or 9 (19.1%), respectively. The majority of HIV-1 subtypes found were CRF-02 and A, although subtypes D, C, G, J and B were also found, reflecting the subtypes known to be circulating in Senegal. There was no significant difference in HIV-1 subtype distribution between individuals with confirmed dual infection and patients in this study with dual seropositivity but lacking HIV-2, or with HIV-1 infected patients within the general population in Senegal, although the study was underpowered to detect anything but large differences. The prevalence of HIV-1/HIV-2 dual infection appears to be significantly less than that of dually seropositive individuals and this likely reflects cross-reactive serology. The common HIV-1 subtypes prevalent in West Africa (CRF-02 and subtype A) have a similar distribution to those found in our cohort of dually infected and dually seropositive subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12908935     DOI: 10.1089/088922203322230941

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

1.  Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test.

Authors:  Ming Chang; Katrin Steinmetzer; Dana N Raugi; Robert A Smith; Selly Ba; Fatima Sall; Moussa Seydi; Alassane Niang; ElHadji Ibrahima Sall; Ousseynou Cisse; Katja Rödel; Robert W Coombs; Geoffrey S Gottlieb
Journal:  J Clin Virol       Date:  2017-10-24       Impact factor: 3.168

2.  Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins.

Authors:  José Maria Marcelino; Helena Barroso; Fátima Gonçalves; Sofia Marques Silva; Carlos Novo; Perpétua Gomes; Ricardo Camacho; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

3.  Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.

Authors:  N N Zheng; N B Kiviat; P S Sow; S E Hawes; A Wilson; H Diallo-Agne; C W Critchlow; G S Gottlieb; L Musey; M J McElrath
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa.

Authors:  Hilary K Whitham; Stephen E Hawes; Haitao Chu; J Michael Oakes; Alan R Lifson; Nancy B Kiviat; Papa Salif Sow; Geoffrey S Gottlieb; Selly Ba; Marie P Sy; Shalini L Kulasingam
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-05-17       Impact factor: 4.254

5.  Capsid proteins from human immunodeficiency virus type 1 and simian immunodeficiency virus SIVmac can coassemble into mature cores of infectious viruses.

Authors:  Jianbo Chen; Vinay K Pathak; Weiqun Peng; Wei-Shau Hu
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

6.  Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform.

Authors:  Ming Chang; Geoffrey S Gottlieb; Joan A Dragavon; Stephen L Cherne; Donna L Kenney; Stephen E Hawes; Robert A Smith; Nancy B Kiviat; Papa Salif Sow; Robert W Coombs
Journal:  J Clin Virol       Date:  2012-07-24       Impact factor: 3.168

7.  HIV type 2 protease, reverse transcriptase, and envelope viral variation in the PBMC and genital tract of ARV-naive women in Senegal.

Authors:  Geoffrey S Gottlieb; Stephen E Hawes; Kim G Wong; Dana N Raugi; Habibatou D Agne; Cathy W Critchlow; Nancy B Kiviat; Papa Salif Sow
Journal:  AIDS Res Hum Retroviruses       Date:  2008-06       Impact factor: 2.205

8.  Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.

Authors:  Natalie N Zheng; M Juliana McElrath; Papa-Salif Sow; Stephen E Hawes; Habibatou Diallo-Agne; Joshua E Stern; Fusheng Li; Andrew L Mesher; Akeliah D Robinson; Geoffrey S Gottlieb; Yunda Huang; Nancy B Kiviat
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

9.  HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4⁺ cell counts.

Authors:  Dana N Raugi; Geoffrey S Gottlieb; Papa S Sow; Macoumba Toure; Fatima Sall; Awa Gaye; Ibra N'doye; Nancy B Kiviat; Stephen E Hawes
Journal:  AIDS       Date:  2013-09-24       Impact factor: 4.177

10.  Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States.

Authors:  S M Owen; C Yang; T Spira; C Y Ou; C P Pau; B S Parekh; D Candal; D Kuehl; M S Kennedy; D Rudolph; W Luo; N Delatorre; S Masciotra; M L Kalish; F Cowart; T Barnett; R Lal; J S McDougal
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.